NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Switzerland's Roche beat market expectations for adjusted net income in the first six months of the year, helped by cancer drug sales but also inflated by a one-off gain from its pensions scheme. Core earnings per share, adjusted for certain items, rose 7 percent to 7.74 Swiss francs ($7.86), where…

news

Drug firm Lupin has launched its generic oral contraceptive Norgestimate and ethinyl estradiol tablets in the American market after receiving nod from the US health regulator. Company's subsidiary "Lupin Pharmaceuticals Inc has launched its Norgestimate and ethinyl estradiol tablets USP, 0.18 mg / 0.035 mg, 0.215 mg / 0.035 mg…

news

Cachet Pharmaceutical Co Ltd Says it planned to set up a a Anhui-based pharmaceutical JV with two individuals. Says the JV will be with a registered capital of 30 million yuan and the co will hold 51 percent stake in it.   Source : reuters.com

news

Drug major Sun Pharma has received final approval from the US health regulator USFDA for rosuvastatin calcium tablets, used in lowering cholesterol. In a BSE filing, Sun Pharma said: "One of its subsidiaries has received final approval from USFDA for its Abbreviated New Drug Application (ANDA) for generic version of…

news

Xoma 358 is in phase 2 development for chi with clinical sites in united states and european union (eu) actively enrolling patients. Xoma receives orphan drug designation in the european union for xoma 358 for treatment of congenital hyperinsulinism.   Source : reuters.com

news

U.S. antitrust officials will file lawsuits to stop the two large health insurance deals they have been scrutinizing for a year, Anthem Inc's (ANTM.N) acquisition of Cigna Corp (CI.N) and Aetna Inc's (AET.N) takeover of Humana Inc (HUM.N), a person familiar with the matter told Reuters. Antitrust regulators have been…

news

Zafgen Inc said it was suspending the development of its lead obesity drug, beloranib, more than six months after the U.S. Food and Drug Administration asked the company to halt all tests on the drug following the death of two patients. Zafgen's shares tumbled more than 40 percent in extended…

news

U.S. regulators have declined to approve Novartis' so-called biosimilar copy of Amgen's Neulasta drug that fights infections in cancer patients, the Swiss drugmaker said on Tuesday. Vasant Narasimhan, head of development at Novartis Pharmaceuticals, said the Food and Drug Administration (FDA) had issued a complete response letter for the product…

news

Indonesia on Monday began re-vaccinating nearly 200 children who received fake versions of imported inoculations from a drug-counterfeiting ring broken up last month after operating for more than a decade. President Joko Widodo urged calm as public uproar intensified over revelations that health officials knew about the syndicate producing the…

news

Some of the world's largest drug companies are taking out their checkbooks for acquisitions of smaller peers whose cancer drugs have the potential to cure not just patients, but corporate growth prospects as well. After decades in which progress meant extending life by weeks or months, new cancer treatments hold…